3 Fast Movers For Today) van--> Riot Blockchain initiated with a Buy, $43 target at B. Riley Flywire 10.44M share IPO priced at $24.00 » 20:13 FLYW PagSeguro Digital reinstated with an Outperform at Bradesco BBI 20:02 PAGS Bradesco BBI analyst Otavio Tanganelli reinstated coverage of PagSeguro Digital with an Outperform rating and $56 price target.
GrowGeneration CEO: We're extremely excited about the East coast 18:45 GRWG In an interview on CNBC's Mad Money, Darren Lampert said GrowGeneration has had a tremendous growth spurt from 2018. All acquisitions the company makes are immediately accretive, he noted. The company buys "best in breed," mature stores that have been around a long time and improves them. "SSS were up 63% last year. We're seeing growth on stores," he said. Lampert expects to see more robust licensing allowing individuals to grow. Up $2 yest @ $39<------
Switch director Thomas sells almost $2M in shares 17:05 SWCH Switch director Thomas Thomas disclosed in a filing that he had sold 100,000 shares of company stock at $19.16 per share between May 21 and May 24 for a total transaction amount of $1,915,890. Ranpak Holdings drops 8% to $22.69 after 5M share offering of Class A common 16:59 PACK XPeng initiated with a Buy at Nomura 16:52 XPEV Nomura analyst Martin Heung initiated coverage of XPeng with a Buy rating and $47 price target, calling the company the best China electronic vehicle player. Salesforce checks show 'strong fundamental demand,' says Jefferies 16:24 CRM Jefferies analyst Brent Thill says his latest survey of survey of 55 partners along with recent checks indicate "sustained strong fundamental demand" for Salesforce. Of those surveyed, 80% saw their Salesforce pipelines improve over the past three months versus 73% last quarter, Thill tells investors in a research note titled "This Ship Is Not Slowing Down." The analyst expects the company to unlock value from Slack over time and finds the risk/reward favorable at current share levels. He keeps a Buy rating on Salesforce with a $300 price target. Uber set to allow U.K. drivers to organize under union, Bloomberg reports 08:02 UBER
Wasn't he just on like 2 months ago lol? And 2 months before that. This was funny: Hey on the CBRL thing... ... ahhhh never mind. You alright Stoney.
Repay and Paysafe team to enable U.S. merchants to accept online cash paymentsRPAY, PSFE Repay Holdings (RPAY)… FDA is set to decline new emergency use authorizations for COVID-19 vaccines May 26, 2021 7:10 AM ETCVAC, INO...Pfizer Inc. (PFE) The FDA has said yesterday it may turn down emergency use authorization (EUA) requests for COVID-19 vaccines for the remainderof the pandemic if the developers have not already begun discussions with the regulator, Reuters reported. Under a EUA, the FDA facilitates the availability and use of unapproved medical products including vaccines during public health emergencies, such as a pandemic. Currently, three COVID-19 vaccines have received FDA’s emergency use approval: Messenger-RNA-based COVID-19 vaccines from Pfizer(NYSE:PFE)/(NASDAQ:BNTX)and Moderna(NASDAQ:MRNA), Adenovirus-based vaccine from Johnson & Johnson(NYSE:JNJ). Meanwhile, AstraZeneca(NASDAQ:AZN)is reportedly seeking full approval for its vector-based vaccine skipping a EUA. Novavax(NASDAQ:NVAX)has previously said, the company has started talks with the FDA for emergency use authorization for its COVID-19 vaccine. However, Novavax has pushed back the timeline for its regulatory submission from Q2 2021 to Q3 2021. Related tickers: Vaxart(NASDAQ:VXRT), Inovio Pharmaceuticals(NASDAQ:INO), Ocugen(NASDAQ:OCGN), CureVac(NASDAQ:CVAC) CVAC Could Plunge! & I'm 90% sure they have started some discussions with FDA so if they clarify mid day this will roar up. -Watch-
Have you seen the really awkward commercial for the antibody cocktails? - Oh it's cringy: Grandma or Mom gets covid and calls hip young child who is jogging... Honey I got the Covid.. Oh no grandma have you heard about antibody cocktails?.. Anti body who? anybody who?... No! AntiBody Cocktails.... You want to have cocktails from Regeneron. Now! When I tell you this? have a cocktail! No! Call your Dr right now and ask about antibody cocktails.. Regeneron shares could gain 5 – 10% on FDA approval for antibody test: Benchmark Regeneron Pharmaceuticals(NASDAQ:REGN)could rise by 5 – 10% subject to FDA approval for low dose antibody product for Covid-19, Benchmark analyst Aydin Huseynov writes. Regeneron is trading ~0.4% higher in the pre-market in below-average volume. With a higher dose product already available, “the FDA does not appear to be in a rush” notes the analyst predicting approximately ~$1B difference for Regeneron’s Q2 sales based on the timing of the low-dose cocktail. Asked about the emergency use authorization for the product, Regeneron CEO Leonard Schleifer said on the recent earnings call: “we anticipate an action by the FDA over the next – sometime in the next several weeks.”
GameStop, AMC surge as 'meme stocks' rally returns The "meme stocks" are back showing strength with GameStop(NYSE:GME)sharesup 8.8%pre-market and AMC Entertainment(NYSE:AMC)isup 8.5%. The companies are popular on Reddit's WallStreetBets forum and on Twitter. Separately, B. Riley downgrades AMC from Buy to Neutral with a $16 price target citing the lofty valuation, though the firm remains confident in the company's 2022-23 box office recovery and opportunity to pick up more market share. Last week, #AMCSqueeze was trending on Twitter, calling attention to the company'snearly 20% short float.
You may be right janes I don't see Nok in there anymore. At one time it was because I had to talk a friend of my son's out of buying too much on his Robin Hood acct! Unfortunately I think he went into Dogicoin instead.
There are some good stocks I sold because they were tech. Weighting wise I had far too much as the sectors turned against me-- so let go of some good ones that were going down.. (SAIL & 8X8) 8x8 joins hands with Sandler Partners to provide 8x8 XCaaS to more than 9,000 technology partners May 26, 2021 9:13 AM ET8x8, Inc. (EGHT)8x8, Inc. (EGHT) 8x8(NYSE:EGHT)announces a strategic partnershipwith Sandler Partners, America’s fastest growing master agent and distributor of connectivity and cloud services. The partnership extends Sandler Partners 9,000 technology partners to enhance 8x8 Experience Communications as a Service. Alan Sandler, Managing Partner and Founder of Sandler Partners, said, “The demand for unified communications and contact center solutions has skyrocketed, as many businesses have shifted to hybrid work environments. 8x8 offers a single-vendor UCaaS and CCaaS solution, and we are thrilled to add them to our growing portfolio of top providers. This partnership with 8x8 will allow our partners to help their clients facilitate and enhance a better employee and customer experience.” Peviously-> 8x8 slips 10% as analysts weigh risks from new strategic plans I sold 8X8 at $33 and now it looks more appealing here at $23<------ Very tough competitor in Ring Central...
i've been accumulating GHVI on market sell-off days at about 11.50/share or under over several months, so i had a bunch, but i sold the majority of them on the rise last week. i didn't think it would keep rising, i thought i'd be buying more at $10.50 asap, so i misread it. the other ones from the thread that i've been buying on sell-offs are coupang CPNG, weird australian thing ASX:SES, and Gamida GMDA. thus far i've been burned by Gamida for buying the dip on it, but i think it's because all its events aren't happening until Q4 so the market has been strangling it on lack of news.